Journal article
Effects of fondaparinux in patients with ST-segment elevation acute myocardial infarction not receiving reperfusion treatment
Abstract
AIMS: At least one quarter of ST-segment elevation myocardial infarction (STEMI) patients do not receive reperfusion therapy, and these patients are at high risk for new ischaemic events. We evaluated fondaparinux treatment vs. usual care, i.e. placebo or unfractionated (UF) heparin, in a pre-specified subgroup of 2867 (out of 12 092) patients not receiving reperfusion treatment in the OASIS-6 trial.
METHODS: In all, 1458 patients were …
Authors
Oldgren J; Wallentin L; Afzal R; Bassand J-P; Budaj A; Chrolavicius S; Fox KAA; Granger CB; Mehta SR; Pais P
Journal
European Heart Journal, Vol. 29, No. 3, pp. 315–323
Publisher
Oxford University Press (OUP)
Publication Date
February 2008
DOI
10.1093/eurheartj/ehm578
ISSN
0195-668X